In my January 13, 2026 post I disclose the purchase of 45 shares @ ~$535.7467 in a 'Core' account in the FFJ Portfolio. The sole purpose of this post is to disclose the purchase of 55 shares @ ~$522.2094 in a 'Side' account in the FFJ Portfolio. Valuation Using my January 27 ~$522.2094 purchase price [...]
My last RTX Corporation (RTX) review was in this in this July 29, 2024 post at which time my conclusion was that shares were no longer on sale. At the time of that post, the Q2 and YTD2024 results were the most current. With the release of Q4 and FY2025 results on January 27, I [...]
In my September 3, 2025 Intuitive Surgical (ISRG) post, I disclose the purchase of an additional 194 shares @ $447.26 in 2 different ‘Core’ accounts within the FFJ Portfolio. Following the release of Q3 and YTD2025 results, I published my October 23, 2025 post at which time I conclude shares are richly valued @ ~$543. [...]
The purpose of this brief post is to disclose the purchase of an additional 200 Thomson Reuters Corporation (TRI) shares on January 20, 2026 @ $USD122.72 in one of the 'Core' accounts in the FFJ Portfolio. In my December 15, 2025 post I disclose my rationale for initiating a new position. I conclude that post [...]
I last reviewed Intact Financial (IFC.to) in this October 20, 2025 post, at which time the Q3 and YTD2025 results (as of September 30, 2025) were the most current. In that post, I disclose the purchase of 100 shares @ $259.85 in a 'Core' account in the FFJ Portfolio. On January 19, 2026, I increased [...]
In my January 6, 2026 Veeva (VEEV) post, I disclose the purchase of an additional 100 shares @ ~$234.115 thus bringing my exposure to 700 shares in a ‘Core’ account in the FFJ Portfolio. Subsequent to this purchase, VEEV's share price has, fortunately, experienced weakness thus providing the opportunity to acquire an additional 100 shares [...]
I last reviewed Mastercard (MA) in this November 3, 2024 post at which time the most currently available financial results were for Q3 and YTD2024. I, however, subsequently disclosed the purchase of additional shares in this April 7, 2025 post. In my 2025 Year-End Investment Holdings Review I disclose that MA remains my second [...]
I last reviewed Lockheed Martin (LMT) in this January 29, 2025 post. In that post, I disclose the purchase of 50 shares @ $457.75 in one of the 'Core' accounts in the FFJ Portfolio on January 28. This purchase increased my exposure to 620 shares. With the automatic reinvestment of dividend income, my exposure is [...]
There are no material changes subsequent to my October 25, 2025 post. The purpose of this brief post, therefore, is merely to disclose the purchase of an additional 100 shares @ $266.875 on January 6, 2026 in a 'Core' account in the FFJ Portfolio. Dividends and Share Repurchases Dividend and Dividend Yield The following is [...]
I last reviewed Veeva Systems (VEEV) in this November 21, 2025 post at which time the Q3 and YTD2026 results had just been released following the November 20, 2025 market close. At the end of Q3, the company had ~$1.66B in cash and cash equivalents and ~$4.977B in short-term investments. Meanwhile, its total liabilities amounted to [...]
